{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T19:23:16Z","timestamp":1789068196626,"version":"build-2803163510"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,3]],"date-time":"2017-07-03T00:00:00Z","timestamp":1499040000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical Research Council Mitochondrial Biology Unit","award":["101876\/Z\/13\/Z"],"award-info":[{"award-number":["101876\/Z\/13\/Z"]}]},{"name":"Medical Research Council Mitochondrial Biology Unit","award":["MC_UP_1501\/2"],"award-info":[{"award-number":["MC_UP_1501\/2"]}]},{"DOI":"10.13039\/501100013372","name":"Wellcome Trust Centre for Mitochondrial Research","doi-asserted-by":"crossref","award":["096919Z\/11\/Z"],"award-info":[{"award-number":["096919Z\/11\/Z"]}],"id":[{"id":"10.13039\/501100013372","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Medical Research Council (UK) Centre for Translational Muscle Disease","award":["G0601943"],"award-info":[{"award-number":["G0601943"]}]},{"name":"EU FP7 TIRCON"},{"name":"National Institute for Health Research (NIHR) Biomedical Research Centre"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.neulet.2017.06.051","type":"journal-article","created":{"date-parts":[[2017,6,28]],"date-time":"2017-06-28T16:46:34Z","timestamp":1498668394000},"page":"132932","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"special_numbering":"C","title":["Mitochondria in neuroinflammation \u2013 Multiple sclerosis (MS), leber hereditary optic neuropathy (LHON) and LHON-MS"],"prefix":"10.1016","volume":"710","author":[{"given":"David","family":"Bargiela","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick F","family":"Chinnery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2017.06.051_bib0005","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1038\/ng.2770","article-title":"Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis","volume":"45","author":"International Multiple Sclerosis Genetics Consortium (IMSGC)","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neulet.2017.06.051_bib0010","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/ng.2802","article-title":"Meta-analysis of 74 046 individuals identifies 11 new susceptibility loci for Alzheimer's disease","volume":"45","author":"Lambert","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neulet.2017.06.051_bib0015","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nature14252","article-title":"Conserved epigenomic signals in mice and humans reveal immune basis of Alzheimer's disease","volume":"518","author":"Gjoneska","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.neulet.2017.06.051_bib0020","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nature11307","article-title":"TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis","volume":"488","author":"Gregory","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.neulet.2017.06.051_bib0025","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nrn.2016.7","article-title":"TREM2 variants: new keys to decipher Alzheimer disease pathogenesis","volume":"17","author":"Colonna","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neulet.2017.06.051_bib0030","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.bbabio.2015.05.015","article-title":"Mitochondrial DNA mutations in neurodegeneration","volume":"1847","author":"Keogh","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neulet.2017.06.051_bib0035","series-title":"McAlpine's Multiple Sclerosis","first-page":"71","article-title":"The distribution of multiple sclerosis","author":"Compston","year":"2006"},{"key":"10.1016\/j.neulet.2017.06.051_bib0040","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/ana.23882","article-title":"The changing clinical course of multiple sclerosis: a matter of gray matter","volume":"74","author":"Calabrese","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neulet.2017.06.051_bib0045","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/ana.24241","article-title":"Spinal cord gray matter atrophy correlates with multiple sclerosis disability","volume":"76","author":"Schlaeger","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neulet.2017.06.051_bib0050","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1136\/jnnp-2014-308241","article-title":"Spinal cord grey matter abnormalities are associated with secondary progression and physical disability in multiple sclerosis, Journal of Neurology","volume":"86","author":"Kearney","year":"2015","journal-title":"Neurosurgery Psychiatry"},{"key":"10.1016\/j.neulet.2017.06.051_bib0055","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neulet.2017.06.051_bib0060","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/brain\/awu397","article-title":"Differential diagnosis of Mendelian and mitochondrial disorders in patients with suspected multiple sclerosis","volume":"138","author":"Weisfeld-Adams","year":"2015","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.neulet.2017.06.051_bib0065","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nri3871","article-title":"Immunopathology of multiple sclerosis","volume":"15","author":"Dendrou","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.neulet.2017.06.051_bib0070","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1136\/jnnp.62.3.285","article-title":"Gadolinium enhanced MRI predicts clinical and MRI disease activity in relapsing-remitting multiple sclerosis","volume":"62","author":"Koudriavtseva","year":"1997","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neulet.2017.06.051_bib0075","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S0140-6736(98)03053-0","article-title":"Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis Group","volume":"353","author":"Kappos","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.neulet.2017.06.051_bib0080","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/ana.22109","article-title":"Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis","volume":"69","author":"Campbell","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neulet.2017.06.051_bib0085","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1600-0404.1998.tb07301.x","article-title":"Is the mitochondrial DNA involved in determining susceptibility to multiple sclerosis","volume":"98","author":"Kalman","year":"1998","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.neulet.2017.06.051_bib0090","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1212\/01.wnl.0000289194.89359.a1","article-title":"Multiple sclerosis-like disorder in OPA1-related autosomal dominant optic atrophy","volume":"70","author":"Verny","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2017.06.051_bib0095","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/brain\/awq007","article-title":"Multi-system neurological disease is common in patients with OPA1 mutations","volume":"133","author":"Yu-Wai-Man","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.neulet.2017.06.051_bib0100","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/acn3.323","article-title":"A multiple sclerosis-like disorder in patients with OPA1 mutations","volume":"3","author":"Yu-Wai-Man","year":"2016","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.neulet.2017.06.051_bib0105","doi-asserted-by":"crossref","DOI":"10.1001\/archneurol.2010.219","article-title":"POLG1 variations presenting as multiple sclerosis","volume":"67","author":"Echaniz-Laguna","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neulet.2017.06.051_bib0110","doi-asserted-by":"crossref","first-page":"e1004369","DOI":"10.1371\/journal.pgen.1004369","article-title":"Recent mitochondrial DNA mutations increase the risk of developing common late-onset human diseases","volume":"10","author":"Hudson","year":"2014","journal-title":"PLoS Genet."},{"key":"10.1016\/j.neulet.2017.06.051_bib0115","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1212\/WNL.0000000000001744","article-title":"Mitochondrial DNA sequence variation in multiple sclerosis","volume":"85","author":"Tranah","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2017.06.051_bib0120","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.clim.2008.07.011","article-title":"Association of common mitochondrial DNA variants with multiple sclerosis and systemic lupus erythematosus","volume":"129","author":"Vyshkina","year":"2008","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.neulet.2017.06.051_bib0125","doi-asserted-by":"crossref","first-page":"e1530","DOI":"10.1371\/journal.pone.0001530","article-title":"mtDNA nt13708A variant increases the risk of multiple sclerosis","volume":"3","author":"Yu","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.neulet.2017.06.051_bib0130","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nrg3966","article-title":"The dynamics of mitochondrial DNA heteroplasmy: implications for human health and disease","volume":"16","author":"Stewart","year":"2015","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.neulet.2017.06.051_bib0135","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.bbadis.2013.10.016","article-title":"Molecular and bioenergetic differences between cells with African versus European inherited mitochondrial DNA haplogroups: implications for population susceptibility to diseases","volume":"1842","author":"Kenney","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neulet.2017.06.051_bib0140","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1093\/hmg\/ddu065","article-title":"Inherited mitochondrial DNA variants can affect complement, inflammation and apoptosis pathways: insights into mitochondrial-nuclear interactions","volume":"23","author":"Kenney","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neulet.2017.06.051_bib0145","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1093\/hmg\/ddv173","article-title":"Mitochondrial DNA variants can mediate methylation status of inflammation, angiogenesis and signaling genes","volume":"24","author":"Atilano","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neulet.2017.06.051_bib0150","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0022-510X(00)00343-9","article-title":"Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis","volume":"177","author":"Lu","year":"2000","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neulet.2017.06.051_bib0155","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/ana.20736","article-title":"Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients","volume":"59","author":"Dutta","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neulet.2017.06.051_bib0160","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s12031-008-9115-1","article-title":"Variations in mitochondrial DNA copy numbers in MS brains","volume":"35","author":"Blokhin","year":"2008","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.neulet.2017.06.051_bib0165","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1365-2990.2008.00987.x","article-title":"Review: mitochondria and disease progression in multiple sclerosis","volume":"34","author":"Mahad","year":"2008","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.neulet.2017.06.051_bib0170","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1093\/brain\/awm236","article-title":"Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity?","volume":"130","author":"Marik","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.neulet.2017.06.051_bib0175","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/jnen\/62.1.25","article-title":"Preferential loss of myelin-Associated glycoprotein reflects hypoxia-Like white matter damage in stroke and inflammatory brain diseases","volume":"62","author":"Aboul-Enein","year":"2003","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neulet.2017.06.051_bib0180","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.1523\/JNEUROSCI.0525-08.2008","article-title":"Nmnat delays axonal degeneration caused by mitochondrial and oxidative stress","volume":"28","author":"Press","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2017.06.051_bib0185","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1523\/JNEUROSCI.20-06-02094.2000","article-title":"Exacerbated responses to oxidative stress by an Na(+) load in isolated nerve terminals: the role of ATP depletion and rise of [Ca(2\u202f+\u202f)](i)","volume":"20","author":"Chinopoulos","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2017.06.051_bib0190","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bbadis.2009.07.002","article-title":"Is multiple sclerosis a mitochondrial disease?","volume":"1802","author":"Mao","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neulet.2017.06.051_bib0195","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/ana.21381","article-title":"Imaging correlates of decreased axonal Na\u202f+\/K +ATPase in chronic multiple sclerosis lesions","volume":"63","author":"Young","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neulet.2017.06.051_bib0200","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nrn2023","article-title":"Axonal conduction and injury in multiple sclerosis: the role of sodium channels","volume":"7","author":"Waxman","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neulet.2017.06.051_bib0205","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/brain\/124.6.1114","article-title":"Distribution of a calcium channel subunit in dystrophic axons in multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"124","author":"Kornek","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.neulet.2017.06.051_bib0210","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1749-6632.2002.tb04446.x","article-title":"Regulation of voltage-Dependent sodium channel expression in adrenal chromaffin cells","volume":"971","author":"Kobayashi","year":"2002","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neulet.2017.06.051_bib0215","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S1474-4422(16)30165-X","article-title":"Mechanisms of glutamate toxicity in multiple sclerosis: biomarker and therapeutic opportunities","volume":"15","author":"Macrez","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neulet.2017.06.051_bib0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2015.04.042","article-title":"AMPA receptor activation causes preferential mitochondrial Ca2+ load and oxidative stress in motor neurons","volume":"1616","author":"Joshi","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.neulet.2017.06.051_bib0225","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1523\/JNEUROSCI.20-01-00240.2000","article-title":"AMPA exposures induce mitochondrial Ca(2 +) overload and ROS generation in spinal motor neurons in vitro","volume":"20","author":"Carriedo","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2017.06.051_bib0230","doi-asserted-by":"crossref","first-page":"10479","DOI":"10.1073\/pnas.1300410110","article-title":"Mitochondrial calcium uptake","volume":"110","author":"Williams","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neulet.2017.06.051_bib0235","doi-asserted-by":"crossref","first-page":"11825","DOI":"10.1074\/jbc.M110.153049","article-title":"Dual-specific phosphatase-6 (Dusp6) and ERK mediate AMPA receptor-induced oligodendrocyte death","volume":"286","author":"Domercq","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2017.06.051_bib0240","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s12013-014-0006-5","article-title":"Autophagy of mitochondria: a promising therapeutic target for neurodegenerative","volume":"70","author":"Kamat","year":"2014","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.neulet.2017.06.051_bib0245","series-title":"GeneReviews\u00ae","first-page":"1993","article-title":"2000)","author":"Yu-Wai-Man","year":"2017"},{"key":"10.1016\/j.neulet.2017.06.051_bib0250","first-page":"196","article-title":"Ein beitrag zur Kenntsnis der familiarhereditared Sehnervenatrophie","author":"Mauksch","year":"1925","journal-title":"Augenheilk"},{"key":"10.1016\/j.neulet.2017.06.051_bib0255","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1002\/mus.880181417","article-title":"Mitochondrial DNA diseases: genotype and phenotype in leber's hereditary optic neuropathy","volume":"18","author":"Harding","year":"1995","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neulet.2017.06.051_bib0260","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1212\/WNL.43.12.2720","article-title":"Association of the 11778 mitochondria1 DNA mutation and demyelinating disease","volume":"43","author":"Flanigan","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2017.06.051_bib0265","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/ana.410360121","article-title":"Leber's hereditary optic neuropathy mitochondrial DNA mutations in multiple sclerosis","volume":"36","author":"Kellar-Wood","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neulet.2017.06.051_bib0270","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1600-0404.1995.tb07016.x","article-title":"Leber's hereditary optic neuropathy associated with a disorder indistinguishable from multiple sclerosis in a male harbouring the mitochondrial DNA 11778 mutation","volume":"91","author":"Olsen","year":"1995","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.neulet.2017.06.051_bib0275","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/0022-510X(95)00287-C","article-title":"Leber's hereditary optic neuropathy with the 11 778 mtDNA mutation and white matter disease resembling multiple sclerosis: clinical, MRI and MRS findings","volume":"135","author":"Jansen","year":"1996","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neulet.2017.06.051_bib0280","first-page":"703","article-title":"Genetic and biochemical impairment of mitochondrial complex I activity in a family with Leber hereditary optic neuropathy and hereditary spastic dystonia","volume":"58","author":"De Vries","year":"1996","journal-title":"Am. J. Hum. Genet."},{"issue":"Pt (2)","key":"10.1016\/j.neulet.2017.06.051_bib0285","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/brain\/118.2.319","article-title":"The clinical features of Leber's hereditary optic neuropathy defined by the presence of a pathogenic mitochondrial DNA mutation","volume":"118","author":"Riordan-Eva","year":"1995","journal-title":"Brain"},{"key":"10.1016\/j.neulet.2017.06.051_bib0290","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1177\/135245859500100106","article-title":"Mitochondrial DNA mutations in multiple sclerosis","volume":"1","author":"Kalman","year":"1995","journal-title":"Mult. Scler."},{"key":"10.1016\/j.neulet.2017.06.051_bib0295","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1212\/WNL.45.7.1333","article-title":"No association of the 11778 mitochondrial DNA mutation and multiple sclerosis in Japan","volume":"45","author":"Nishimura","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2017.06.051_bib0300","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/135245859700200603","article-title":"Screening for leber's hereditary optic neuropathy associated mitochondrial dna mutations in patients with prominent optic neuritis","volume":"2","author":"Kalman","year":"1997","journal-title":"Mult. Scler."},{"key":"10.1016\/j.neulet.2017.06.051_bib0305","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/1531-8249(200008)48:2<188::AID-ANA8>3.0.CO;2-P","article-title":"The epidemiology of pathogenic mitochondrial DNA mutations","volume":"48","author":"Chinnery","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neulet.2017.06.051_bib0310","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/ana.21217","article-title":"Prevalence of mitochondrial DNA disease in adults","volume":"63","author":"Schaefer","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neulet.2017.06.051_bib0315","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/ana.24362","article-title":"Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease","volume":"77","author":"Gorman","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neulet.2017.06.051_bib0320","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1212\/WNL.0000000000001995","article-title":"Prevalence of neurogenetic disorders in the North of England","volume":"85","author":"Bargiela","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2017.06.051_bib0325","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1212\/01.wnl.0000437308.22603.43","article-title":"Clinical features of MS associated with Leber hereditary optic neuropathy mtDNA mutations","volume":"81","author":"Pfeffer","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2017.06.051_bib0330","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1016\/j.ophtha.2013.04.022","article-title":"Dominant optic atrophy: novel OPA1 mutations and revised prevalence estimates","volume":"120","author":"Yu-Wai-Man","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.neulet.2017.06.051_bib0335","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1136\/jnnp.2008.144667","article-title":"Increasing prevalence and incidence of multiple sclerosis in South East Wales","volume":"80","author":"Hirst","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neulet.2017.06.051_bib0340","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1136\/jmg.39.3.162","article-title":"Leber hereditary optic neuropathy","volume":"39","author":"Man","year":"2002","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.neulet.2017.06.051_bib0345","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.preteyeres.2010.11.002","article-title":"Mitochondrial optic neuropathies \u2212 Disease mechanisms and therapeutic strategies","volume":"30","author":"Yu-Wai-Man","year":"2011","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.neulet.2017.06.051_bib0350","doi-asserted-by":"crossref","first-page":"20065","DOI":"10.1073\/pnas.1217113109","article-title":"Mouse mtDNA mutant model of Leber hereditary optic neuropathy","volume":"109","author":"Lin","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neulet.2017.06.051_bib0355","series-title":"Biochimica Et Biophysica Acta","author":"Mao","year":"2013"},{"key":"10.1016\/j.neulet.2017.06.051_bib0360","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/ana.24006","article-title":"Neurological deficits caused by tissue hypoxia in neuroinflammatory disease","volume":"74","author":"Davies","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neulet.2017.06.051_bib0365","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.neuroscience.2006.10.002","article-title":"Mitochondrial DNA repair: a critical player in the response of cells of the CNS to genotoxic insults","volume":"145","author":"LeDoux","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.neulet.2017.06.051_bib0370","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/978-1-59745-521-3_15","article-title":"Targeting repair proteins to the mitochondria of mammalian cells through stable transfection, transient transfection, viral transduction, and TAT-mediated protein transduction","volume":"554","author":"Koczor","year":"2009","journal-title":"Methods Mol. Biol."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394017305438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394017305438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T17:17:42Z","timestamp":1568827062000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394017305438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":74,"alternative-id":["S0304394017305438"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2017.06.051","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mitochondria in neuroinflammation \u2013 Multiple sclerosis (MS), leber hereditary optic neuropathy (LHON) and LHON-MS","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2017.06.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}],"article-number":"132932"}}